Newron to Present at the 16th International Congress on Schizophrenia Research

MILAN, Mar 16, 2017 (BUSINESS WIRE) — Newron Pharmaceuticals S.p.A. (“Newron”), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, today announces that Ravi Anand, M.D.


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.